Xiaohong Tan

机构：Beijing Proteome Research Center · ORCID：0000-0003-4700-4562

发表论文 75 篇 · 总被引 4126 次 · h-index 29

代表论文

• Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation (2021 · Nature Communications · 被引 76)
• EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma (2020 · PLoS ONE · 被引 35)
• CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma (2021 · Journal of Translational Medicine · 被引 29)
• Baseline and interim 18F-FDG PET/CT metabolic parameters predict the efficacy and survival in patients with diffuse large B-cell lymphoma (2024 · Frontiers in Oncology · 被引 15)
• Comparison of the Efficacy and Safety of Axi-Cel and Tisa-Cel Based on Meta-Analysis (2024 · Journal of Cancer · 被引 11)
• Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p (2023 · PLoS ONE · 被引 8)